Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    Video

    ARISTOPHANES: Apixaban edges other DOACS for octogenarians 

    December 2, 2018

    CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds.

  • 1
    News

    Invasive strategy increased bleeding risk in frail older AMI patients

    November 19, 2018

    Registry analysis suggests frailty in an AMI patient calls for personalized decision making.

  • 1
    News

    Resuming DOAC therapy in AF patients after gastrointestinal bleed

    November 15, 2018

    For patients who develop a gastrointestinal bleed (GIB) while using direct oral anticoagulant (DOAC) therapy for atrial fibrillation (AF), does the risk of venous thromboembolism (VTE) or recurrent GIB increase after DOAC resumption?

  • 1
    News

    PIONEER-HF called “practice changing” for acute decompensated heart failure

    November 12, 2018

    CHICAGO – In-hospital initiation of sacubitril/valsartan safely and significantly reduced heart failure rehospitalizations in the next 8 weeks.

  • 1
    News

    Burden of atrial fibrillation associated with stroke risk

    November 12, 2018

    In patients with paroxysmal atrial fibrillation (PAF), is the burden of atrial fibrillation associated with increased risk of ischemic stroke?

  • 1
    Video

    PIONEER-HF secures place for sacubitril/valsartan in this heart failure doc’s practice 

    November 11, 2018

    CHICAGO – The designated discussant for the PIONEER-HF presentation points out the importance of the results.

  • News

    Apixaban is safest effective DOAC for stroke prevention in Afib, per AHRQ report

    November 10, 2018

    The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.

  • 1
    News

    Lower glucose targets show improved mortality in cardiac patients

    November 9, 2018

    Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.

  • 1
    News

    BNP levels and mortality in patients with and without heart failure

    November 7, 2018

    Does B-type natriuretic peptide (BNP) have prognostic value outside of heart failure (HF) patients?

  • 1
    News

    CT opens extended window for stroke thrombolysis

    November 1, 2018

    MONTREAL – The new EXTEND findings “will have a major impact” on using an extended time window for thrombolysis in U.S. practice.

Previous1 … 52 53 54 55 56 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences